Schedule & Agenda

Below is the 2020 schedule and agenda for the BIO CEO & Investor Conference. 

BIO CEO & Investor Conference
Date
  • Show All
Time
  • Show All
Jump to Day
  • Show All
Monday, February 10
9:00 AM - 9:55 AM
As PD-1/L1 checkpoint inhibitors continue to reveal new tumor types those drugs can attack…
11:00 AM - 11:55 AM
Small and mid-sized biotech companies commercially launched 42% of U.S. new drug approvals in 2018,…
1:30 PM - 2:25 PM
Approximately 5% of people in the U.S. are at risk for NASH and it is on track to be the dominant…
2:30 PM - 3:25 PM
Polls of U.S. public confidence in prescription drug companies have dropped so far that multiple…
3:30 PM - 4:25 PM
Fewer than 20 gene therapies have so far been approved in the global market. With more than 750…
4:30 PM - 5:45 PM
Despite a record number of large deals across the pharmaceutical and biotechnology landscape,…
Tuesday, February 11
9:00 AM - 9:55 AM
According to the World Health Organization, cardiovascular diseases are the leading cause of death…
10:00 AM - 10:55 AM
Barbara Dalton, PhD is Vice President, WWBD and Senior Managing Partner of Pfizer Ventures. Barbara…
11:00 AM - 11:55 AM
Dr. Love joined GBT in June 2014 as president and chief executive officer with broad leadership and…
12:00 PM - 12:55 PM
As the Principal Deputy Commissioner of Food and Drugs, Dr. Amy P. Abernethy, M.D., Ph.D., helps…
1:00 PM - 1:55 PM
BIO in partnership with the Center for Talent Innovation will launch the first report on building…
2:00 PM - 2:55 PM
Michael M. Morrissey, Ph.D., is President and Chief Executive Officer at Exelixis and a member of…
3:00 PM - 3:55 PM
In recent months, the exits of several large companies from the neuroscience space, optimistic…
4:00 PM - 4:55 PM
With the close out of 2019 at record levels and 2020 in full swing, the biotechnology sector has…
Wednesday, February 12
8:30 AM - 1:00 PM
The course is an optional registration add-on for the BIO CEO & Investor Conference, but conference…